Importantly, the finding that mRNA vaccination in IBD patients receiving TNF inhibitors leads to the activation of T cells with an IFN-γ/IL-2/IL-10 secretion profile indicates that comparable functional profiles could also arise in virus-specific T cells following SARS-CoV-2 infection. Here, IFNG is linked to inflammatory bowel disease.